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Abstract
Background: Grb2-associated binding (Gab) adapter proteins play major roles in coordinating signaling downstream of
hematopoietic cytokine receptors. In hematopoietic cells, Gab2 can modulate phosphatidylinositol–3 kinase and mitogen
associated protein kinase activities and regulate the long-term multilineage competitive repopulating activity of
hematopoietic stem cells (HSCs). Gab2 may also act in a linear pathway upstream or downstream of signal transducer and
activator of transcription-5 (STAT5), a major positive regulator of HSC function. Therefore, we aimed to determine whether
Gab2 and STAT5 function in hematopoiesis in a redundant or non-redundant manner.
Methodology/Principal Findings: To do this we generated Gab2 mutant mice with heterozygous and homozygous
deletions of STAT5. In heterozygous STAT5 mutant mice, deficiencies in HSC/multipotent progenitors were reflected by
decreased long-term repopulating activity. This reduction in repopulation function was mirrored in the reduced growth
response to early-acting cytokines from sorted double mutant c-Kit
+Lin
2Sca-1
+ (KLS) cells. Importantly, in non-ablated
newborn mice, the host steady-state engraftment ability was impaired by loss of Gab2 in heterozygous STAT5 mutant
background. Fetal liver cells isolated from homozygous STAT5 mutant mice lacking Gab2 showed significant reduction in
HSC number (KLS CD150
+CD48
2), reduced HSC survival, and dramatic loss of self-renewal potential as measured by serial
transplantation.
Conclusions/Significance: These data demonstrate new functions for Gab2 in hematopoiesis in a manner that is non-
redundant with STAT5. Furthermore, important synergy between STAT5 and Gab2 was observed in HSC self-renewal, which
might be exploited to optimize stem cell-based therapeutics.
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Introduction
Grb2-associated binding protein-2 (Gab2) is tyrosine phosphor-
ylated by several early acting cytokine receptors such as Flt3, c-Kit,
interleukin (IL)-3R, and c-Mpl and contains binding sites for SH2
and SH3 domains that promote binding to signaling molecules
[1–3]. Gab2 activates the phosphatidylinositol-39-kinase (PI3-K)
and the mitogen activated protein kinase (MAPK) pathways and
can regulate hematopoietic cell survival, proliferation, cytoskeleton
reorganization, and adhesion/migration functions[2,4–7]. The
original cloning and description of Gab2 showed that a Gab2
mutant lacking amino acids 604–662 impaired IL-3 induced signal
transducer and activator of transcription-5 (STAT5) activation in
BaF3 cells, indicating that Gab2 may act upstream of STAT5[1].
We have previously identified Gab2 as located on a chromosome 7
STAT5 modifier locus, containing several hundred genes, that
modulates hematopoietic stem cell (HSC) engraftment during
steady-state hematopoiesis[8]. STAT5 is a latent transcription
factor that can be activated by phosphorylation by Janus kinases
(JAKs) in the cytoplasm, leading to dimerization, DNA binding,
and retention within the nucleus[9]. STAT5 is a major regulator
of hematopoietic development in multiple hematopoietic lineages
and is essential for HSC ‘‘fitness’’ as characterized by competitive
repopulation of lethally-irradiated hosts[10,11].
Cross-talk between JAK/STAT5 and PI3-K pathways has been
described in hematopoietic and non-hematopoietic cells. Interac-
tion between these pathways is important for pro-survival
signaling[12] in neural cells. Several reports in IL-2 responsive
hematopoietic cell lines also suggest that STAT5 and PI3-K play
important roles in cytokine responsiveness. In response to IL-2, a
delayed cycloheximide-sensitive mechanism for coordinated cyclin
D2 expression involves both PI3-K and STAT5 activation[13].
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mediated stimulation of Akt activation through the IL-2
receptor[14] suggesting that Gab2 might function downstream
of STAT5. Another study showed that mutation of the SH2-
containing phosphatase (SHP-2) binding sites of Gab2 influenced
STAT5 activation and proliferation in response to IL-2[15]. Since
STAT5 is a substrate for SHP-2 phosphatase[16], this study
demonstrates another unique manner in which Gab2 might
function upstream of STAT5.
STAT5 and PI3-K activation is also observed downstream of
thrombopoietin (TPO)/c-Mpl signaling to regulate the expression
level of the direct STAT5 target gene Bcl-XL[17]. TPO/c-Mpl
signaling is critically important for HSC repopulation, self-
renewal, and interaction with the HSC niche[18–21]. Enhanced
sensitivity to inhibition of STAT5, SHP-2, and Gab2[22] has also
been described in Bcr/Abl-induced oncogenic activities. Based on
these lines of evidence, we initially hypothesized that Gab2 may
depend entirely on STAT5 in HSC to regulate important
functions such as survival and self-renewal. Since all prior work
in this area has been done in cultured cell lines, it was important to
analyze mouse models of STAT5 and Gab2. To date, work with
single Gab2 or STAT5 knockout mice has shown similar
phenotypes in mast cells, where STAT5 and Gab2 are involved
in IL-3/SCF signaling[4,23–25]. STAT5 was much more critical
for early hematopoiesis including HSC self-renewal[10], whereas
Gab2 was active in multilineage hematopoietic repopulation but
was not essential for serial transplantation ability[26].
Considering that Gab2 promotes the PI3-K and Erk pathways
and may act upstream or downstream of STAT5, we set out to
determine whether STAT5 and Gab2 function in a redundant or
non-redundant manner to control HSC function. The relationship
between STAT5- and Gab2-mediated signals in early hematopoi-
esis was explored at the genetic level through generation and
characterization of compound mutant mice. We studied hemato-
poiesis at various stages of development as permitted by the
limiting survival of STAT5ab
null/null mice and found that Gab2
has functions that are non-redundant with STAT5 in controlling
HSC survival and self-renewal.
Materials and Methods
Mice, Fetal Liver Isolation and Genotyping
STAT5ab
+/null mice were obtained from Lothar Hennighausen
(NIDDK, NIH)[27]. Gab2
2/2 mice were obtained from Toshio
Hirano (Osaka University)[4]. The C57BL/6 (CD45.2) mice and
the congenic B6.SJL-Ptprc
aPep3
b/BoyJ (CD45.1) strain were
obtained from the Jackson Laboratory (Bar Harbor, ME). All
mutant mice were on the C57BL/6 background and housed in a
specific pathogen-free environment. All mouse studies were
approved by the Institutional Animal Care and Use Committee
at Case Western Reserve University. Gab2
+/2STAT5ab
+/null
mice were inter-crossed to yield Gab2
2/2STAT5ab
null/null double
knockout embryos. Fetal liver (FL) cells from these embryos were
collected at embryonic day 14.5 (E14.5) and genotyped the same
day by PCR. The following primers were used for STAT5
genotyping: 59-AGC AGC AAC CAG AGG ACT AC-39,5 9-GAA
AGC ATG AAA GGG TTG GAG-39 and 59-CCC ATT ATC
ACC TTC TTT ACA G-39. The following primers were used for
Gab2 genotyping: 59-AAT GTA GAC AGT CAG TGC CTA
GAG GGT CCA-39;5 9-CAT GTA TCA TGA CAT TTG TGC
TCC AAC A-39, and 59-CAG CAG CCT CTG TTC CAC ATA
CAC TTC AT-39. The PCR parameters for genotyping fetal liver
DNA were: 94uC, 30 sec.; 55uC, 30 sec.; 72uC, 1 min. for 35
cycles.
Mouse Peripheral Blood Hematology
Peripheral blood was obtained following puncture of the
retroorbital venous sinus using a microcapillary tube. For red
and white blood cell counts, cells were diluted in isotonic saline
solution and analyzed using a Coulter counter (Beckman Coulter,
Inc., Fullerton, CA).
Colony-Forming Unit Assay
Total CFU-C colonies were assayed by standard methods
according to the Stem Cell Technologies manual. Briefly, either
fetal liver or BM cells were plated in EPO-containing MethoCult
GF M3334 methylcellulose medium (Stem Cell Technologies,
Vancouver, BC, Canada) with added recombinant murine IL-3
(20 ng/ml), recombinant human IL-6 (50 ng/ml), recombinant
murine stem cell factor (SCF; 50 ng/ml). On day 7 of culture,
colonies of greater than 50 cells were counted and the frequency of
total CFU-C per 1610
5 cells was calculated based on the input
number of BM cells. All hematopoietic cytokines were from R&D
Systems (Minneapolis, MN).
Flow Cytometric Determination of BM and Fetal Liver
HSC Numbers
Fetal liver or BM cells were harvested in PBS/2% FBS
(Hyclone). For BM stem cell staining, after erythrocyte lysis, PE-
conjugated lineage markers, Ly-6G (Gr-1), CD11b (Mac-1),
CD45R/B220, CD4 (L3T4), CD8 (Ly2), and Ter119/Ly76 were
used. The cells also were stained with antibodies to fluorescein
isothiocyanate (FITC)-conjugated Ly-6A/E (Sca-1) and to APC-
conjugated CD117 (c-Kit). Anti Flk2 conjugated to Pacific Blue
(PB) was used to define short-term repopulating HSC (KLS Flk2
+)
and long-term repopulating HSCs (KLS Flk2
neg). After antibody
staining, 7-amino-actinomycin D (7-AAD) at 2 mg/ml was added
into cells and incubated for 20 min immediately before flow
cytometry to exclude dead cells. Staining for fetal liver stem cells
was slightly different. PE-conjugated lineage markers were the
same for BM cell staining except that CD11b (Mac-1) was not
included. The fetal liver cells were also stained with c-Kit-APC
and Sca-1-FITC and in some analyses with CD150-APC-Cy7 and
CD48-PB. All flow cytometry was performed on a BD LSRII with
4 lasers (355 nM solid state UV laser, 405 nM solid state violet
laser, 488 nM solid state blue laser, 633 nM red HeNe laser)
(Becton Dickinson, Franklin Lakes, NJ). The data were analyzed
using the FlowJo software program (Tree Star, Ashland, OR).
Flow Cytometric Assay for FL HSC Survival
To analyze cell death in FL HSC, E14.5 FL cells were counted
and stained with biotin-conjugated antibodies to the lineage
markers Ly-6G (Gr-1), CD45R/B220, CD4 (L3T4), CD8 (Ly2),
and Ter119/Ly76. Cells were incubated with anti-biotin microbe-
ads (Miltenyi Biotec), followed by AutoMACS depletion through a
fresh separation column. The negative pass-through fraction
(LN
2) was counted and 5610
5 cells were stained with the above
lineage markers and anti-c-Kit-APC and anti-Sca-1-PE-Cy7. The
lineage markers were detected by a secondary streptavidin-APC-
Cy7 step. Finally, the cells were stained with Annexin V-PE (BD
Bioscience) and DAPI (Invitrogen) according to the manufactur-
er’s instructions.
Long-Term Repopulation and Secondary Transplantation
For fetal liver non-competitive transplantation, 8- to 12-week-
old male B6.SJL-Ptprc
aPep3
b/BoyJ mice were lethally irradiated
with 11 Gy using c
137Cs Shepherd Mark I irradiator (JL
Shepherd, San Fernando, CA). The entire population of E14.5
Gab2 Function in HSC
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transplanted into 5 recipient mice by intravenous injection
through the lateral tail vein. Donor engraftment was monitored
8–16 weeks after transplantation by staining with antibodies to
CD45.2 and to individual lineage markers that included CD4,
B220, Gr-1, or Ter119. Peripheral blood cells were counted by
Coulter counter as described above.
Competitive Repopulation Assays
For BM competitive transplantation, BM cells from CD45.2
donor mice were mixed with CD45.1 competitor mouse BM cells
at a 1:1 ratio. The mixed cells were then transplanted into lethally
irradiated CD45.1 B6.SJL-Ptprc
aPep3
b/BoyJ recipient mice (1100
rads). Donor engraftment was monitored 8–16 weeks after
transplantation by staining with antibody to CD45.2 and
antibodies to lineage-specific antigens. For newborn injection
experiments, 2–3 day old newborn pups were injected intraper-
itoneally with donor adult BM cells exactly as described
previously[8].
Statistical Analyses
For multiple comparisons, two-way ANOVA analysis was used.
We also use either one-way ANOVA, or Wilcoxon-Mann-
Whitney U tests for wild-type vs. mutant single comparisons. P
values of less than 0.05 were considered statistically significant. All
statistics were performed using SPSS16.0 (SPSS, Inc.) or
StatistiXL 1.8, which is designed and written by Alan Roberts
and Philip Withers (University of Western Australia., Australia).
Student’s two-tailed T test was performed using InStat 1.5
(University of Reading, UK).
Results
Cell Intrinsic Functional Defects in Gab2
2/2STAT5ab
+/null
HSC
To assess whether STAT5 and Gab2 were redundant during
normal hematopoiesis, compound mutant mice with targeted
alleles of STAT5 and Gab2 were generated and characterized at
various developmental stages. Comparisons between adult STA-
T5ab
+/null and Gab2
2/2 genotype was the first measure tested,
since both Gab2
2/2 and STAT5ab
+/null mice and their Gab2
2/2
STAT5ab
+/null cross were born at normal Mendelian ratio and
had no apparent defects in survival long-term. No evidence of
Gab2-mediated defects in peripheral blood hematology were
observed, similar to our prior study, and Gab2 deletion did not
decrease blood counts in STAT5ab
+/null mice (Fig. S1A). Since
the peripheral blood counts were unaffected by the double mutant,
we focused on the BM compartment and determined that the
absolute number of LT-HSC were normal in all single and double
mutant mice (Fig. S1B).
Since peripheral blood counts and steady-state BM cellularity
do not provide indicators of stress hematopoiesis, we next tested
KLS cytokine stimulation which measures a combination of
growth and differentiation response, which differs significantly
from maintenance of the steady-state HSC pool in vivo.K L S
cells were sorted into 96 well plates and stimulated with
cytokines as previously described[26,28] (Fig. 1). Significant
declines in cytokine response were observed for deficiency of
S T A T 5o rG a b 2a l o n e ,a sw e l la sf u r t h e rd e c r e a s e si nG a b 2
2/2
STAT5ab
+/null KLS cells relative to single mutants in cocktails
containing IL-3, IL-6, and SCF (Gab2
2/2STAT5ab
+/null vs.
Figure 1. Combined deficiency of Gab2 with heterozygous STAT5 reduces KLS cell responses to early acting cytokines. KLS cells were
sorted by flow cytometry and plated in 96-well plates in the presence of various cytokine cocktails. Total nucleated cells were counted 6 days later. IL-
3 indicates murine IL-3 (20 ng/ml); 6, human IL-6 (50 ng/ml); S, murine stem cell factor (50 ng/ml); F, murine Flt3-ligand (50 ng/ml); and T, murine
thrombopoietin (50 ng/ml). The cell expansion in each group of cytokines was plotted relative to wild-type control cells for each stimulation
experiment. The results are the average 6 SD for 3 experiments. Absolute cell expansions were comparable to previous descriptions[26,28].
doi:10.1371/journal.pone.0009152.g001
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2/2, P=0.03; Gab2
2/2STAT5ab
+/null vs. STAT5ab
+/null,
P,0.01, t-test) or with IL-3, SCF, Flt-3 ligand, and TPO (Gab2
2/2
STAT5ab
+/null vs. Gab2
2/2, P=0.02; Gab2
2/2STAT5ab
+/null vs.
STAT5ab
+/null,P ,0.01, t-test). Notably these cytokine combina-
tions induce the strongest proliferation and differentiation from
purified KLS cells. To determine whether defects were also
observed in vivo, BM cells were harvested and transplantation
experiments performed. Two independent competitive repopulation
experiments were performed using adult BM cells with the same
results. The average results of the two transplantation experiments
are shown in Fig. 2A. STAT5ab
+/null and Gab2
2/2 BM had
competitive multilineage HSC repopulating defects averaging
36.766.4% and 17.563.5% of wild-type respectively. Notably,
Gab2
2/2STAT5ab
+/null BM cells had an average 9.561.7% of
wild-type engraftment. The percentage of donor engraftment
between single mutant (Gab2
2/2 or STAT5ab
+/null)a n dG a b 2
2/2
STAT5ab
+/null were significantly different (P,0.001 for STA-
T5ab
+/nullGab2
2/2 vs. STAT5ab
+/null or Gab2
2/2STAT5ab
+/null
vs. Gab2
2/2, Mann-Whitney U test). The reduction of donor
engraftment in Gab2
2/2STAT5ab
+/null mice was significant
(P,0.001, 2-way ANOVA). Further multilineage analysis showed
that the long-term reductions in repopulation occurred in a
primitive cell type (Fig. 2B). STAT5ab
+/null and Gab2
2/2 mice
were significantly different for all lineages (P=0.001 for Gr-1 and
P,0.001 for all others; 2-way ANOVA).
STAT5 and Gab2 Promote Long-Term Multilineage
Engraftment in Non-Ablated Newborn Mice
Non-ablated engraftment of newborn mice is a very stringent
test for HSC function. In these transplants, we found that
STAT5ab
+/null hosts could be significantly engrafted on average 8-
fold higher when injected with 1610
7 BM cells as newborn pups
(Fig. 3A)( P ,0.01, Mann-Whitney U test). In contrast, wild-type
mice showed very low levels of engraftment. As expected, no
STAT5ab
null/null mice were obtained due to perinatal lethality.
Mice lacking Gab2 expression could also be engrafted significantly
at 16-fold higher levels than wild-type control mice (P,0.01,
Mann-Whitney U test), with levels similar to those of STAT5
haploinsufficiency. Strikingly, deletion of Gab2 combined with
STAT5 haploinsufficiency led to a synergistic 40-fold rise in long-
term engraftment levels averaging 55623%. The combination
of STAT5ab
+/2 and Gab2
2/2 genotype allowed significantly
increased donor engraftment (P,0.001; 2-way ANOVA). Differ-
ences between single mutants and Gab2
2/2STAT5ab
+/null were
significant (Gab2
2/2 vs. Gab2
2/2STAT5ab
+/null, P=0.042 and
STAT5ab
+/null vs. Gab2
2/2STAT5ab
+/null, P=0.001; Mann-
Whitney U test). Multilineage donor engraftment was observed
in lethally-irradiated recipients of secondary transplantation
(Fig. 3B). No significant differences were observed in secondary
reconstitution (1-way ANOVA), except there was a modest
significant difference between Gab2
2/2 and Gab2
2/2STA-
T5ab
+/null
in B220
+ cells (Mann-Whitney U test).
Decreased Fetal Liver CFU-C, HSC Number, and HSC
Survival in the Complete Absence of Both STAT5 and
Gab2
Since STAT5ab
null/null mice were not alive at the newborn or
adult stages of development, we analyzed E14.5 fetal liver (FL)
where STAT5ab
null/null embryos can survive[29]. At E14.5, the
expected Mendelian ratio (1/16) of double mutant was obtained
(15/231), indicating the STAT5/Gab2 double mutant embryos
have no overall survival disadvantage at this stage of development.
However, the CFU-C frequency of STAT5ab
null/nullGab2
2/2 FL
was reduced to 24% of normal (N=4) compared with STAT-
5ab
null/null or Gab2
2/2 FL whose CFU-C frequency were
reduced to 58% and 39% of wild-type respectively (Fig. 4A).
The Gab2
2/2STAT5ab
null/null CFU-C frequency was signifi-
cantly lower than either Gab2
2/2 or STAT5ab
null/null groups
(P,0.006, Mann-Whitney U Test; P=0.014, 2-way ANOVA).
The specific types of myeloid CFU-C were not enumerated for
these studies since prior work showed that STAT5 and Gab2
mutant mice have reduced numbers of all types with no particular
bias toward a single lineage.
Since the number of CFU-C was most reduced in double
mutant FL cells, we examined more primitive HSC populations by
flow cytometry for the frequency of HSC. The KLS and the LT-
HSC fraction (KLS CD150
+CD48
2) population were found to be
present at normal number in FL cells lacking either STAT5 or
Gab2. Gating for each of these populations is shown in Fig. S2.
However, when both STAT5 and Gab2 were deleted, the absolute
number of total HSC and LT-HSC was significantly reduced by 2-
to 3-fold relative to wild-type (Fig. 4B, 4C). Differences between
Figure 2. Combined deficiency of Gab2 with heterozygous
STAT5 leads to declines in adult HSC activity. A. BM cells from 3–
5 donor mice were collected and mixed 1:1 with wild-type competitor
(CD45.1) and transplanted into lethally-irradiated hosts for competitive
repopulation analysis. Recipient mice were bled 12 weeks later for flow
cytometry analysis. Shown is the average of two independent
experiments with 5 mice per group in each experiment. B. At 16
weeks post transplant, mice were bled again for multilineage analysis
for the same two independent experiments. Peripheral blood
leukocytes were stained with antibodies to multiple lineage markers
including Gr-1, B220, Ter119, and CD4.
doi:10.1371/journal.pone.0009152.g002
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2/2 or STAT5ab
null/null) and Gab2
2/2
STAT5ab
null/null were significant (P,0.001; Mann-Whitney U
test). The reduction of KLS cells (P=0.009; 2-way ANOVA) and
LT-HSC (P,0.001; 2-way ANOVA) in STAT5ab
null/null and
Gab2
2/2 was synergistic, suggesting that maintenance of the FL
HSC pool depends upon both STAT5 and Gab2 together.
To better understand why KLS cell numbers were reduced, FL
lineage-negative and KLS populations were analyzed by flow
cytometry to determine the fraction of Annexin V stained cells. A
marked increase in early apoptosis as measured by increased
Annexin V
+DAPI
2 cells was observed for double mutant FL cells
relative to wild-type littermate control (Fig. 5). The difference was
significantly higher than either STAT5 or Gab2 mutant alone.
Significantly reduced cell survival was observed in the KLS
fraction (P=0.02; 2-way ANOVA), but not in the LIN- fraction
(P=0.056; 2-way ANOVA), indicating non-redundant function in
regulating survival occurred in primitive HSC, a finding that is
consistent with the reduced KLS number only in the STAT5/
Gab2 double mutant mice.
Synergistic Defects in Self-Renewal of Fetal Liver HSC
Completely Lacking Both STAT5 and Gab2
To determine whether double mutant FL HSC were capable of
long-term engraftment of irradiated hosts, total FL cells from 3
independent embryos or different litters were transplanted into
CD45.1 recipient mice at a donor to recipient ratio of 1 FL per 5
recipient mice. The percentage of donor CD45.2 engraftment
was determined at times up to 16 weeks later (Fig. 6A). The
donor engraftment was not significantly changed by combined
STAT5ab
null/null and Gab2
2/2 genotype (P=0.415; 2-way
ANOVA). Differences between STAT5ab
null/null and Gab2
2/2
STAT5ab
null/null were not significant (P=0.104; Mann-Whitney
U test). When analyzing the overall contribution of the donor to
host hematopoiesis, there was a trend toward lower levels of
donor chimerism and 3/15 primary recipients did not survive
transplantation. Importantly, defects in reconstitution obtained
with STAT5ab
null/null FL cells were consistent with prior work
showing declines in T and B lymphocytes (Fig. 6B). As expected,
Gab2 deficiency alone did not have any impact upon hemato-
poietic reconstitution in the absence of a competitor. Differences
between STAT5ab
null/null and Gab2
2/2STAT5ab
null/null were
not significant (P=0.383; Mann-Whitney U test). Even in the
complete absence of STAT5 and Gab2, no additional declines
were observed in steady-state hematopoiesis in recipients of
double mutant FL transplant relative to STAT5ab
null/null alone.
Since primary FL transplant cannot measure true HSC self-
renewal potential, we collected BM cells from primary hosts and
performed BM transplant into lethally-irradiated secondary hosts.
Strikingly, 11 out of 15 secondary recipients of Gab2
2/2
STAT5ab
null/null FL cells did not survive transplantation up to
12 weeks later, indicating a severe decrease in HSC self-renewal
capacity (Fig. 7A). Following 12 weeks of reconstitution of the
secondary hosts, the surviving recipients of Gab2
2/2STAT-
5ab
null/null BM were analyzed for donor chimerism along with
all of the surviving control mice from the other three groups
(Fig. 7B). The data show gating for the percentage of donor
contribution of CD45.2 engraftment. The donor engraftment
was significantly reduced by STAT5ab
null/null Gab2
2/2 genotype
Figure 3. Combined deficiency of Gab2 with heterozygous STAT5 allows replacement of newborn HSC with a donor graft. A. Pups
generated from inter-cross of Gab2
+/2STAT5ab
+/null mice were injected intraperitoneally with 1610
7 CD45.1 positive BM cells 2–3 days after birth. At
4 weeks of age, the newly weaned mice were genotyped for STAT5 and Gab2. From multiple sets of experiments, totals of WT N=22; STAT5ab
+/null
N=27; Gab2
2/2 N=9; and Gab2
2/2STAT5ab
+/null N=5 mice were obtained and analyzed for evidence of long-term donor engraftment. B. At 16
weeks following injection, the mice were analyzed by flow cytometry of the peripheral blood leukocytes for engraftment with CD45.1 positive donor
cells. Horizontal bars indicate the average for all mice analyzed per group. All comparisons were done by Mann-Whitney U test. C. BM was pooled
from primary recipients and injected into 5 lethally-irradiated secondary recipients. Individual primary donors utilized for secondary transplantation
are marked in panel B by open circles. The percentage of CD45.1 positive cells co-staining for Gr-1, B220, Ter119, or CD4 is shown from secondary
transplantation and analysis 12 weeks later. The wild-type group was not included in the secondary transplantation since the primary recipients had
little to no evidence of donor engraftment.
doi:10.1371/journal.pone.0009152.g003
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PLoS ONE | www.plosone.org 5 February 2010 | Volume 5 | Issue 2 | e9152(P=0.004; 2-way ANOVA). Differences between STAT5ab
null/null
and Gab2
2/2STAT5ab
null/null was moderately significant (P=
0.032; Mann-Whitney U test). These analyses found extremely
low donor contribution to the secondary hosts, consistent with graft
failure associated with HSC self-renewal deficiency. Accordingly, the
absolute number of Gr-1
+ myeloid cells, a good indicator of real-
time hematopoiesis due to the short-half life of neutrophils, was
reduced to very low levels when both STAT5 and Gab2 were
absent (Fig. 7C).
Discussion
Recent understanding of the impact of cytokine signaling
pathways on HSC homeostasis is beginning to show positive and
negative effects depending on the pathway and degree of activation.
In particular, activation of the PI3-kinase/Akt/mTOR or the Akt/
Foxo pathways can have negative consequences on HSC. Foxo3a is
pro-apoptotic and must be held in check. Mice lacking PTEN[30],
TSC[31], or Foxos[32,33] have increased HSC proliferation,
reduced survival, and loss of repopulating function. Reports of
mutant mice lacking Caspase-3[34] or Foxo3a-mediated loss of
negative feedback by Spred2[35] demonstrate that Erk pathway
activation can also be detrimental to HSC. In contrast, steady-state
levels of STAT5 activation positively regulate HSC homeostasis
and repopulating function[36].
We have previously reported studies of STAT5 or Gab2
knockout mice and characterized their individual role in
hematopoiesis. STAT5 deficiency resulted in severe HSC level
defects and was only modestly required in CFU-C[29]. Gab2
was critical for committed CFU-C and multipotent progenitor
level response to hematopoietic cytokines and for long-term
multilineage competitive repopulating ability of HSC[26]. Gab2
may lie upstream or downstream of STAT5 to promote
hematopoiesis or it may function solely through ERK or
AKT. Therefore, the studies in this report were designed to
identify new Gab2-dependent HSC functions and to determine
whether regulation of HSC activity by Gab2 could be accounted
f o rs o l e l yb yS T A T 5i nal i n e a rs ignaling pathway. To do this,
the effect of combined deficiency of STAT5 and Gab2 on
hematopoiesis was tested following generation of compound
mutant mice.
The defects observed in compound mutant mice were
informative regarding the levels of hematopoiesis where STAT5
and Gab2 play non-redundant roles and the defects uncovered
new functions for Gab2 that were not previously recognized.
Using 2-way ANOVA analysis, strong evidence was obtained for
non-redundant functions of STAT5 and Gab2 during hemato-
poiesis. We found that combined deficiency had no additional
impact upon peripheral blood hematology or BM cellularity in
heterozygous STAT5 mutants. However, combined deficiency
resulted in declines in CFU-C and long-term repopulating activity
relative to STAT5 or Gab2 deficiency alone. These defects were
consistent with the reduced in vitro cytokine response, indicative of
reduced expansion and differentiation.
Newborn engraftment in the absence of myeloablation to clear
the niche and promote hematopoietic engraftment tests the ability
of host HSC to compete with donor HSC for engraftment under
very stringent conditions that are biased against the donor graft. In
Figure 4. STAT5 and Gab2 double mutant fetal liver has reduced CFU-C and HSC. Gab2
2/2STAT5ab
null/null and littermate control mice
derived from Gab2
+/2STAT5ab
+/null inter-cross were generated and characterized. A. Fetal liver cells were plated into methylcellulose medium for
Wild-type N=3; STAT5ab
null/null N=3; Gab2
2/2 N=3; STAT5ab
null/nullGab2
2/2 N=4. All 4 groups were significantly different from each other
(P,0.005, Student’s two-tailed t-test). B. The HSC enriched c-Kit
+Lin
2Sca-1
+ (KLS) population per fetal liver was determined for Wild-type N=3;
STAT5ab
null/null N=4; Gab2
2/2 N=6; STAT5ab
null/nullGab2
2/2 N=5.C. The average number of long-term HSC (KLS CD150
+CD48
2) cells per FL were
determined for Wild-type N=3; STAT5ab
null/null N=6; Gab2
2/2 N=4; Gab2
2/2STAT5ab
null/null N=5.
doi:10.1371/journal.pone.0009152.g004
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PLoS ONE | www.plosone.org 6 February 2010 | Volume 5 | Issue 2 | e9152Figure 5. STAT5 and Gab2 double mutant fetal liver HSCs have reduced survival. Analysis of the frequency of early apoptotic cells by the
Annexin V - DAPI flow cytometry assay on E14.5 FL cells. Early apoptotic cells were defined as Annexin V
+/DAPI
2. A. Percentages of apoptosis in the
lineage-negative fraction. B. Percentages of apoptosis in the KLS fraction. (*: Gab2
2/2STAT5ab
null/null vs. STAT5ab
null/null p,0.05; **: Gab2
2/2
STAT5ab
null/null vs. Gab2
2/2 P,0.05; ***: Gab2
2/2STAT5ab
null/null vs. Wild-type P,0.05; +: Wild-type vs. STAT5ab
null/null p,0.05). For panels A and B,
the numbers of mice in each of the 4 groups were as follows: Wild-type N=4; STAT5ab
null/null N=7; Gab2
2/2 N=3; STAT5ab
null/nullGab2
2/2 N=4.C.
A representative flow cytometry plot showing Annexin V and DAPI gating on KLS cells among the 4 groups.
doi:10.1371/journal.pone.0009152.g005
Figure 6. STAT5 and Gab2 double mutant fetal liver HSCs partially repopulate the myeloid lineage of primary recipients. Gab2
2/2
STAT5ab
null/null and littermate control embryos were used to derive FL cells. FL cells from 3 independent Gab2
2/2STAT5ab
null/null embryos were each
injected into 5 lethally-irradiated CD45.1 positive hosts to determine the hematopoietic repopulating potential. For other groups, 1 FL was injected
into 5 recipient mice. A. The percentage of donor engraftment was determined by flow cytometry for expression of CD45.2. B. Peripheral lympho-
myeloid blood donor contribution was determined by flow cytometry for Gr-1, B220, or CD4, 16 weeks later for three independent transplant
experiments. The total number of mice from all 3 experiments was WT N=5; Gab2
2/2 N=5; STAT5ab
null/null N=5; Gab2
2/2STAT5ab
null/null N=12.
Each dot represents an individual mouse that was analyzed. Horizontal bars indicate the average for all mice analyzed per group.
doi:10.1371/journal.pone.0009152.g006
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PLoS ONE | www.plosone.org 7 February 2010 | Volume 5 | Issue 2 | e9152this setting, loss of one allele of host STAT5 was sufficient to
promote donor engraftment and full deletion of Gab2 alone in the
host permitted significant donor reconstitution. Interestingly, the
observed defects for Gab2
2/2STAT5ab
+/null mice were greater
than predicted for additive. It should also be pointed out that
secondary transplantation showed roughly equivalent levels of
reconstitution from primary recipients with single or compound
mutants. Therefore, the increased donor chimerism associated
with non-ablated engraftment may be more associated with
selection at the BM multipotent progenitor fraction than with the
HSC.
Since in prior studies, Gab2 deficiency was not associated with
defects in HSC self-renewal, we wanted to explore whether
evidence for Gab2 participation in signaling at the HSC level
might be evident in the complete absence of STAT5. STAT5 is
important for HSC self-renewal and promotes competitive
repopulation ability[37]. Using serial transplantation, we were
able to uncover important roles for Gab2 in HSC signaling. In our
prior work[37], STAT5-deficient HSC caused death in quaternary
transplants. However, Gab2-deficient HSC permitted tertiary
transplantation (data not shown[26]). The results of serial
transplant using FL cells from mice completely lacking STAT5
and Gab2 were very striking. The combined defects in secondary
transplant reported here indicate that HSC depletion occurs
following the first transplant, despite reasonable engraftment of the
granulocytic lineage. This type of secondary transplantation failure
is comparable to a recent report of E12.5 FL cells lacking
Wnt3a[38]. Therefore, Gab2 can play an important role in
normal HSC self-renewal in a novel manner by facilitating the role
of STAT5 in HSC function.
To better understand why the HSC number was decreased in
the FL of STAT5/Gab2 double mutant mice, flow cytometry
assay for apoptosis was performed. The results of this assay
indicate that reduced survival can account for the reduction in
HSC number. STAT5 is known to be an important regulator of
survival signaling and Gab2 facilitates Akt-mediated survival
signals. However, the striking reduction in survival signaling is
novel and suggests either direct effects between downstream
targets mediated by STAT5 and PI3-K pathways or cross-talk
between these pathways could be critical for optimal survival
signaling. In the context of competitive repopulation and self-
renewal activities, additional studies will be required to identify
whether defective engraftment is due to additional loss of
proliferative or homing potential. Limitations in the number of
double knockout FL that could be obtained prohibited assays
requiring large HSC numbers. Conditional deletion of STAT5 in
adult BM may provide a tool for future studies.
The unique roles for STAT5/Gab2 interaction during non-
ablated engraftment indicate important function in generation
and maintenance of HSC. The important role of STAT5 in
many aspects of HSC function is now clear. However the
mechanisms of action of STAT5 remain largely undefined.
Defining and targeting interactive signaling nodes has become
important area of research for stem cell transplantation and
eradicating leukemic stem cells. The finding that Gab2 can have
STAT5-independent functions in HSC indicates that activation
of the PI3-K or MAPK pathways could be beneficial for steady-
state HSC function. In addition, these Gab2 functions appear to
synergize with STAT5 in the most critical aspects of HSC
function, namely self-renewal as assayed by serial transplantation.
Figure 7. STAT5 and Gab2 double mutant fetal liver HSCs are defective in repopulation of secondary recipients. At 14 weeks following
transplant, 3 mice from each group were euthanized from the cohorts of Fig. 6 (Wild-type, Gab2
2/2, STAT5ab
null/null, and 3 sets of Gab2
2/2
STAT5ab
null/null). BM cells were pooled from these primary recipient mice and transplanted into lethally-irradiated secondary CD45.1 hosts at a ratio of
1 donor to 5 recipient mice. A. Overall mouse survival was monitored on daily basis for WT N=5; Gab2
2/2 N=4; STAT5ab
null/null N=5; and Gab2
2/2
STAT5ab
null/null N=15. B. Donor engraftment in the peripheral blood of secondary transplanted mice for four combinations of STAT5 and Gab2
genotype that survived past approximately 12 weeks for WT N=5; Gab2
2/2 N=4; STAT5ab
null/null N=5; and Gab2
2/2STAT5ab
null/null N=4.C. The
absolute number of Gr-1 positive cells was determined by antibody staining and flow cytometry combined with the total white blood cell count per
ml of whole blood. Horizontal bars indicate the average for all mice analyzed per group.
doi:10.1371/journal.pone.0009152.g007
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PLoS ONE | www.plosone.org 8 February 2010 | Volume 5 | Issue 2 | e9152A better understanding of the importance of STAT5/Gab2
signals may lead to new approaches for non-ablative HSC
transplantation or therapeutics for hematologic malignancies
where HSC survival and self-renewal are dysregulated.
Supporting Information
Figure S1 No changes in peripheral blood hematology or LT-
HSC from single or compound mutant adult mice. A. Steady-state
peripheral hematology was determined by total WBC counts using
a Coulter counter combined with flow cytometry analysis for cells
staining positive for lineage markers. Lineage antibodies to Gr-1,
Mac-1, B220, Ter119, CD4, and CD8 were used. No significant
differences were observed for any hematologic parameter in WT
(N=11), STAT5ab+/null (N=11), Gab22/2 (N=11), or
Gab22/2STAT5ab+/null (N=13) mice. B. BM cells were
collected and stained with lineage antibodies, combined with the
combination of Sca-1, c-Kit, Flk2 (Flt3), and CD48 and the values
plotted represent the average number of cells per adult mouse (2
tibias and 2 femurs) for WT (N=8), STAT5ab+/null (N=9),
Gab22/2 (N=9), or Gab22/2STAT5ab+/null (N=9) mice.
Found at: doi:10.1371/journal.pone.0009152.s001 (4.19 MB
DOC)
Figure S2 Flow cytometry gating for analysis of FL KLS and
KLS CD150+CD482 populations. FL cells were collected from
E14.5 embryos and stained with antibodies to determine the
percentage of LT-HSC present. Initial gating was performed using
7-AAD to exclude dead FL cells. Within the 7-AAD negative/low
fraction, the cells were gated on forward and side scatter to also
collect the viable fraction. The lineage-negative fraction was then
gated for expression of KLS cells. As an additional measure of the
LT-HSC fraction within the KLS gate, additional gating for
CD150+CD482 cells was performed as shown. Note that the
numbers shown in the right two columns are the frequencies of the
total population, not just the population shown.
Found at: doi:10.1371/journal.pone.0009152.s002 (4.02 MB
DOC)
Acknowledgments
The authors thank Toshio Hirano for providing Gab2 mutant mice.
Author Contributions
Conceived and designed the experiments: GL WT KDB. Performed the
experiments: GL ZW KM YZ. Analyzed the data: GL ZW KM YZ KDB.
Contributed reagents/materials/analysis tools: WT. Wrote the paper: GL
WT KDB.
References
1. Gu H, Pratt JC, Burakoff SJ, Neel BG (1998) Cloning of p97/Gab2, the major
SHP2-binding protein in hematopoietic cells, reveals a novel pathway for
cytokine-induced gene activation. Mol Cell 2: 729–740.
2. Nishida K, Yoshida Y, Itoh M, Fukada T, Ohtani T, et al. (1999) Gab-family
adapter proteins act downstream of cytokine and growth factor receptors and T-
and B-cell antigen receptors. Blood 93: 1809–1816.
3. Crouin C, Arnaud M, Gesbert F, Camonis J, Bertoglio J (2001) A yeast two-
hybrid study of human p97/Gab2 interactions with its SH2 domain-containing
binding partners. FEBS Lett 495: 148–153.
4. Nishida K, Wang L, Morii E, Park SJ, Narimatsu M, et al. (2002) Requirement
of Gab2 for mast cell development and KitL/c-Kit signalling. Blood 99:
1866–1869.
5. Yu M, Luo J, Yang W, Wang Y, Mizuki M, et al. (2006) The scaffolding adapter
Gab2, via Shp-2, regulates kit-evoked mast cell proliferation by activating the
Rac/JNK pathway. J Biol Chem 281: 28615–28626.
6. Yu WM, Hawley TS, Hawley RG, Qu CK (2002) Role of the docking protein
Gab2 in beta(1)-integrin signaling pathway- mediated hematopoietic cell
adhesion and migration. Blood 99: 2351–2359.
7. Sun J, Pedersen M, Ronnstrand L (2008) Gab2 is involved in differential
phosphoinositide 3-kinase signaling by two splice forms of c-Kit. J Biol Chem
283: 27444–27451.
8. Couldrey C, Bradley HL, Bunting KD (2005) A STAT5 modifier locus on
murine chromosome 7 modulates engraftment of hematopoietic stem cells
during steady-state hematopoiesis. Blood 105: 1476–1483.
9. Iyer J, Reich NC (2008) Constitutive nuclear import of latent and activated
STAT5a by its coiled coil domain. FASEB J 22: 391–400.
10. Bunting KD, Bradley HL, Hawley TS, Moriggl R, Sorrentino BP, et al. (2002)
Reduced lymphomyeloid repopulating activity from adult bone marrow and
fetal liver of mice lacking expression of STAT5. Blood 99: 479–487.
11. Snow JW, Abraham N, Ma MC, Abbey NW, Herndier B, et al. (2002) STAT5
promotes multilineage hematolymphoid development in vivo through effects on
early hematopoietic progenitor cells. Blood 99: 95–101.
12. Um M, Lodish HF (2006) Antiapoptotic effects of erythropoietin in differentiated
neuroblastoma SH-SY5Y cells require activation of both the STAT5 and AKT
signaling pathways. J Biol Chem 281: 5648–5656.
13. Moon JJ, Rubio ED, Martino A, Krumm A, Nelson BH (2004) A permissive role
for phosphatidylinositol 3-kinase in the Stat5-mediated expression of cyclin D2
by the interleukin-2 receptor. J Biol Chem 279: 5520–5527.
14. Lockyer HM, Tran E, Nelson BH (2007) STAT5 is essential for Akt/p70S6
kinase activity during IL-2-induced lymphocyte proliferation. J Immunol 179:
5301–5308.
15. Arnaud M, Crouin C, Deon C, Loyaux D, Bertoglio J (2004) Phosphorylation of
Grb2-associated binder 2 on serine 623 by ERK MAPK regulates its association
with the phosphatase SHP-2 and decreases STAT5 activation. J Immunol 173:
3962–3971.
16. Chen Y, Wen R, Yang S, Schuman J, Zhang EE, et al. (2003) Identification of
Shp-2 as a Stat5A phosphatase. J Biol Chem 278: 16520–16527.
17. Kirito K, Watanabe T, Sawada K, Endo H, Ozawa K, et al. (2002)
Thrombopoietin regulates Bcl-xL gene expression through Stat5 and phospha-
tidylinositol 3-kinase activation pathways. J Biol Chem 277: 8329–8337.
18. Kimura S, Roberts AW, Metcalf D, Alexander WS (1998) Hematopoietic stem
cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin. Proc
Natl Acad Sci U S A 95: 1195–1200.
19. Fox N, Priestley G, Papayannopoulou T, Kaushansky K (2002) Thrombopoietin
expands hematopoietic stem cells after transplantation. J Clin Invest 110:
389–394.
20. Qian H, Buza-Vidas N, Hyland CD, Jensen CT, Antonchuk J, et al. (2007)
Critical role of thrombopoietin in maintaining adult quiescent hematopoietic
stem cells. Cell Stem Cell 1: 671–684.
21. Yoshihara H, Arai F, Hosokawa K, Hagiwara T, Takubo K, et al. (2007)
Thrombopoietin/MPL signaling regulates hematopoietic stem cell quiescence
and interaction with the osteoblastic niche. Cell Stem Cell 1: 685–697.
22. Scherr M, Chaturvedi A, Battmer K, Dallmann I, Schultheis B, et al. (2006)
Enhanced sensitivity to inhibition of SHP2, STAT5, and Gab2 expression in
chronic myeloid leukemia (CML). Blood 107: 3279–3287.
23. Gu H, Saito K, Klaman LD, Shen J, Fleming T, et al. (2001) Essential role for
Gab2 in the allergic response. Nature 412: 186–190.
24. Barnstein BO, Li G, Wang Z, Kennedy S, Chalfant C, et al. (2006) Stat5
expression is required for IgE-mediated mast cell function. J Immunol 177:
3421–3426.
25. Shelburne CP, McCoy ME, Piekorz R, Sexl V, Roh KH, et al. (2003) Stat5
expression is critical for mast cell development and survival. Blood 102:
1290–1297.
26. Zhang Y, Diaz-Flores E, Li G, Wang Z, Kang Z, et al. (2007) Abnormal
hematopoiesis in Gab2 mutant mice. Blood 110: 116–124.
27. Cui Y, Riedlinger G, Miyoshi K, Tang W, Li C, et al. (2004) Inactivation of
Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions
in cell proliferation, survival, and differentiation. Mol Cell Biol 24: 8037–8047.
28. Bradley HL, Hawley TS, Bunting KD (2002) Cell intrinsic defects in cytokine
responsiveness of STAT5-deficient hematopoietic stem cells. Blood 100:
3983–3989.
29. Li G, Wang Z, Zhang Y, Kang Z, Haviernikova E, et al. (2007) STAT5 requires
the N-domain to maintain hematopoietic stem cell repopulating function and
appropriate lymphoid-myeloid lineage output. Exp Hematol 35: 1684–1694.
30. Zhang J, Grindley JC, Yin T, Jayasinghe S, He XC, et al. (2006) PTEN
maintains haematopoietic stem cells and acts in lineage choice and leukaemia
prevention. Nature 441: 518–522.
31. Chen C, Liu Y, Liu R, Ikenoue T, Guan KL, et al. (2008) TSC-mTOR
maintains quiescence and function of hematopoietic stem cells by repressing
mitochondrial biogenesis and reactive oxygen species. J Exp Med 205:
2397–2408.
32. Miyamoto K, Araki KY, Naka K, Arai F, Takubo K, et al. (2007) Foxo3a is
essential for maintenance of the hematopoietic stem cell pool. Cell Stem Cell 1:
101–112.
33. Tothova Z, Kollipara R, Huntly BJ, Lee BH, Castrillon DH, et al. (2007) FoxOs
are critical mediators of hematopoietic stem cell resistance to physiologic
oxidative stress. Cell 128: 325–339.
34. Janzen V, Fleming HE, Riedt T, Karlsson G, Riese MJ, et al. (2008)
Hematopoietic stem cell responsiveness to exogenous signals is limited by
caspase-3. Cell Stem Cell 2: 584–594.
Gab2 Function in HSC
PLoS ONE | www.plosone.org 9 February 2010 | Volume 5 | Issue 2 | e915235. Miyamoto K, Miyamoto T, Kato R, Yoshimura A, Motoyama N, et al. (2008)
FoxO3a regulates hematopoietic homeostasis through a negative feedback
pathway in conditions of stress or aging. Blood 112: 4485–4493.
36. Wang Z, Li G, Tse W, Bunting KD (2009) Conditional deletion of STAT5 in
adult mouse hematopoietic stem cells causes loss of quiescence and permits
efficient nonablative stem cell replacement. Blood 113: 4856–4865.
37. Bradley HL, Couldrey C, Bunting KD (2004) Hematopoietic-repopulating
defects from STAT5-deficient bone marrow are not fully accounted for by loss of
thrombopoietin responsiveness. Blood 103: 2965–2972.
38. Luis TC, Weerkamp F, Naber BA, Baert MR, de Haas EF, et al. (2009) Wnt3a
deficiency irreversibly impairs hematopoietic stem cell self-renewal and leads to
defects in progenitor cell differentiation. Blood 113: 546–554.
Gab2 Function in HSC
PLoS ONE | www.plosone.org 10 February 2010 | Volume 5 | Issue 2 | e9152